ArticleFrontiers in medicine2026
Two-hour dynamic reassessment of noninvasive ventilation failure risk in acute exacerbation of chronic obstructive pulmonary disease with hypercapnic respiratory failure: development and temporal validation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early recognition of noninvasive ventilation (NIV) failure remains difficult in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) with hypercapnic respiratory failure. We developed and temporally validated a model for structured reassessment after early NIV treatment and compared it with a pre-NIV model and the heart rate, acidosis, consciousness, oxygenation, and respiratory rate (HACOR) score. Methods: The hospital information system identified consecutive NIV-treated AECOPD admissions from 2021 through 2025. After prespecified data-consistency exclusions, 924 first eligible hospitalizations were divided by calendar time into development and temporal-validation cohorts. The dynamic model used the first complete physiological assessment obtained 90-150 min after NIV initiation. Discrimination, calibration, clinical utility, and robustness were evaluated; detailed analytic methods and supporting results are provided in the Supplementary material. Results: NIV failure occurred in 136 of 692 patients in development and 51 of 232 in temporal validation. The dynamic model retained good discrimination and close calibration in validation. Its numerical performance was slightly better than the pre-NIV model and HACOR-derived probability, but superiority was not established. Respiratory rate and level of consciousness at reassessment carried the clearest independent prognostic information, whereas the contributions of acidosis, oxygenation, and pneumonia were more context dependent. Conclusion: The model provides a reproducible probability estimate for structured early treatment-response reassessment, but it does not replace HACOR, clinical judgment, or established escalation criteria. External validation and prospective impact evaluation are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.